ARCHIVES

NIH Objects To Big Response On Immunology RFPs, But NCI Will Continue Wide Distribution

This article is from The Cancer Letter archive.

Vol. 01 No. 39 | November 1, 1974

Download PDF Visit The Full Archive

Related Articles

In Vote Against Tarceva As Maintenance, ODAC Seeks Stronger Survival Benefit

December 18, 2009

Funding opportunities listed.

May 28, 2004

NIH to ban consulting by top officials, limit outside work by other employees.

June 25, 2004

HHS Task Force Says NCI Drug Program Effective, Otters Suggestions; DeVita Responds

March 26, 1982

Letter: A Modest Proposal To Abolish FDA

January 26, 1996

Funding opportunities listed.

February 27, 2004